![Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon - ScienceDirect Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S009167492031407X-fx1.jpg)
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon - ScienceDirect
![Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/569479692535494216/primaryPicture/true/fodoid/571872364885442989/imageType/LARGE/inlineImage/true/coronavirus-albuterol-shortage-asthma-medicine-BT.png)
Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma | Asthma and Allergy Foundation of America
![Please Don't Stop Your Asthma Medicines – An Editorial From Dr. Mitchell Grayson on the Coronavirus (COVID-19) | Asthma and Allergy Foundation of America Please Don't Stop Your Asthma Medicines – An Editorial From Dr. Mitchell Grayson on the Coronavirus (COVID-19) | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/567790766058316201/primaryPicture/true/fodoid/567790766058316307/imageType/LARGE/inlineImage/true/Coronavirus-and-fears-with-asthma-v2-BT.png)
Please Don't Stop Your Asthma Medicines – An Editorial From Dr. Mitchell Grayson on the Coronavirus (COVID-19) | Asthma and Allergy Foundation of America
![Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/c8a53fd8-7246-40de-acd7-9d497f8dee0c/gr1_lrg.gif)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR](https://www.nihr.ac.uk/images/news/PRINCIPLE-inhaler-budesonide.png)
Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial — Nuffield Department of Primary Care Health Sciences, University of Oxford
![What People with Asthma Need to Know About COVID-19: Regional Allergy, Asthma & Immunology Center: Allergy and Immunology What People with Asthma Need to Know About COVID-19: Regional Allergy, Asthma & Immunology Center: Allergy and Immunology](https://sa1s3optim.patientpop.com/assets/images/provider/photos/2331456.jpg)
What People with Asthma Need to Know About COVID-19: Regional Allergy, Asthma & Immunology Center: Allergy and Immunology
![Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/thumbnail_BUDESONIDE_COMPOSITE.jpg?itok=5_9Ln01t)